Pfizer Partnership Philosophy Relies On One Manager, Five “C”s
Pfizer relies on one manager to oversee all aspects of an R&D agreement to help ensure that the goals identified in creating the partnership translate into day-to-day practice
You may also be interested in...
Pfizer relies on competition among research teams to help ensure that its vast R&D resources do not diminish the entrepreneurial spirit within the organization, CFO David Shedlarz told the Merrill Lynch pharmaceutical and biotechnology conference Feb. 5 in New York City
Pfizer's $1.3 bil. acquisition of Esperion will reunite the Lipitor research team and give Pfizer two more chances to develop a novel mechanism anti-atherosclerotic agent
Pfizer expects its partners to defer to Pfizer in areas where it has a clear advantage in established skills and size, rather than push the joint arrangements as a way for the smaller firm to develop new functions